Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine

Abstract Background Methamphetamine (MA) use among pregnant women is an increasing problem in the United States. The impact of prenatal MA exposure on development in childhood is unknown. Objective To examine the effects of prenatal MA exposure on motor and cognitive development in children at 1, 2,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurotoxicology and teratology 2011-01, Vol.33 (1), p.176-184
Hauptverfasser: Smith, Lynne M, LaGasse, Linda L, Derauf, Chris, Newman, Elana, Shah, Rizwan, Haning, William, Arria, Amelia, Huestis, Marilyn, Strauss, Arthur, Della Grotta, Sheri, Dansereau, Lynne M, Lin, Hai, Lester, Barry M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 184
container_issue 1
container_start_page 176
container_title Neurotoxicology and teratology
container_volume 33
creator Smith, Lynne M
LaGasse, Linda L
Derauf, Chris
Newman, Elana
Shah, Rizwan
Haning, William
Arria, Amelia
Huestis, Marilyn
Strauss, Arthur
Della Grotta, Sheri
Dansereau, Lynne M
Lin, Hai
Lester, Barry M
description Abstract Background Methamphetamine (MA) use among pregnant women is an increasing problem in the United States. The impact of prenatal MA exposure on development in childhood is unknown. Objective To examine the effects of prenatal MA exposure on motor and cognitive development in children at 1, 2, and 3 years of age. Design/methods IDEAL enrolled 412 mother–infant pairs at four sites (Tulsa OK, Des Moines IA, Los Angeles CA, and Honolulu HI). MA subjects (n = 204) were identified by self report or GC/MS confirmation of amphetamine and metabolites in infant meconium. Comparison subjects (n = 208) were matched (race, birth weight, maternal education, and type of insurance), denied amphetamine use, and had a negative meconium screen. Both groups included prenatal alcohol, tobacco and marijuana use, but excluded use of opiates, lysergic acid diethylamide, phencyclidine or cocaine only. The Peabody Developmental Motor Scales (PDMS-2) were administered to the infants at the 1 and 3 year visits. This analysis includes a subsample (n = 350) of the IDEAL study with completed 1 and/or 3 year visits (n = 330 and 281, respectively). At each annual visit we also conducted the Bayley Scales of Infant Development (BSID-II) as a general evaluation of mental and motor development. The BSID-II analysis includes a subsample (n = 356) of the IDEAL study with completed 1, 2, and/or 3 year visits (n = 331, 288, and 278 respectively). GLM analysis conducted on the PDMS-2 and BSID-II examined the effects of MA exposure and heavy MA exposure (≥ 3 days of use/week), with and without covariates. Longitudinal analyses were used to examine the effects of MA exposure on changes in motor and cognitive performance over time. Results Heavy MA exposure was associated with significantly lower grasping scores than some and no use at 1 year (P = 0.018). In longitudinal analysis, lower grasping scores associated with any MA exposure and heavy exposure persisted to 3 years. There were no effects of MA exposure, including heavy exposure, on the Bayley Mental Development Index (MDI) or Psychomotor Development Index (PDI) at any or across age. Conclusions There were no differences in cognition as assessed by the BSID-II between the groups. There was a subtle MA exposure effect on fine motor performance at 1 year with the poorest performance observed in the most heavily exposed children. By 3 years, no differences in fine motor performance were observed. These findings suggest MA exposure has mod
doi_str_mv 10.1016/j.ntt.2010.10.004
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3033584</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0892036210001868</els_id><sourcerecordid>860378466</sourcerecordid><originalsourceid>FETCH-LOGICAL-c537t-465b7fcda58d614d30e4e16fdede944ec9b519140000f7f9535f63d661da0a9f3</originalsourceid><addsrcrecordid>eNp9Uk1v1DAUtBCILoUfwAX5ximLHTtOIqRKqOJLKuJQOFte-yXxktjBdlbdf1-nWyrKgdPTs2fm2TMPodeUbCmh4t1-61LaluSu3xLCn6ANbeqyaGvWPEUb0rRlQZgoz9CLGPeEkFpQ8hydlbSsBGd0g_pvPvmAlTNY-97ZZA-A_ZK0nyDiNAS_9MNaAfARVIjYd1j1gK3DerCjCeAw3Mw-gsHJ4zn3KqkRT5AGNc0DJDVZBy_Rs06NEV7d13P089PHH5dfiqvvn79efrgqdMXqVHBR7epOG1U1RlBuGAEOVHQGDLScg253FW0pz18hXd21Fas6wYwQ1Cii2o6do4uT7rzsJjAaXApqlHOwkwpH6ZWVj2-cHWTvD5IRxqqGZ4G39wLB_14gJjnZqGEclQO_RNkIwuqGC5GR9ITUwccYoHuYQolc85F7mfORaz7rUc4nc978_bwHxp9AMuD9CQDZpIOFIKO24DQYG0Anabz9r_zFP2w9Wme1Gn_BEeLeL8Fl9yWVsZREXq8Lsu4HzXbSRjTsFsvquKM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>860378466</pqid></control><display><type>article</type><title>Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Smith, Lynne M ; LaGasse, Linda L ; Derauf, Chris ; Newman, Elana ; Shah, Rizwan ; Haning, William ; Arria, Amelia ; Huestis, Marilyn ; Strauss, Arthur ; Della Grotta, Sheri ; Dansereau, Lynne M ; Lin, Hai ; Lester, Barry M</creator><creatorcontrib>Smith, Lynne M ; LaGasse, Linda L ; Derauf, Chris ; Newman, Elana ; Shah, Rizwan ; Haning, William ; Arria, Amelia ; Huestis, Marilyn ; Strauss, Arthur ; Della Grotta, Sheri ; Dansereau, Lynne M ; Lin, Hai ; Lester, Barry M</creatorcontrib><description>Abstract Background Methamphetamine (MA) use among pregnant women is an increasing problem in the United States. The impact of prenatal MA exposure on development in childhood is unknown. Objective To examine the effects of prenatal MA exposure on motor and cognitive development in children at 1, 2, and 3 years of age. Design/methods IDEAL enrolled 412 mother–infant pairs at four sites (Tulsa OK, Des Moines IA, Los Angeles CA, and Honolulu HI). MA subjects (n = 204) were identified by self report or GC/MS confirmation of amphetamine and metabolites in infant meconium. Comparison subjects (n = 208) were matched (race, birth weight, maternal education, and type of insurance), denied amphetamine use, and had a negative meconium screen. Both groups included prenatal alcohol, tobacco and marijuana use, but excluded use of opiates, lysergic acid diethylamide, phencyclidine or cocaine only. The Peabody Developmental Motor Scales (PDMS-2) were administered to the infants at the 1 and 3 year visits. This analysis includes a subsample (n = 350) of the IDEAL study with completed 1 and/or 3 year visits (n = 330 and 281, respectively). At each annual visit we also conducted the Bayley Scales of Infant Development (BSID-II) as a general evaluation of mental and motor development. The BSID-II analysis includes a subsample (n = 356) of the IDEAL study with completed 1, 2, and/or 3 year visits (n = 331, 288, and 278 respectively). GLM analysis conducted on the PDMS-2 and BSID-II examined the effects of MA exposure and heavy MA exposure (≥ 3 days of use/week), with and without covariates. Longitudinal analyses were used to examine the effects of MA exposure on changes in motor and cognitive performance over time. Results Heavy MA exposure was associated with significantly lower grasping scores than some and no use at 1 year (P = 0.018). In longitudinal analysis, lower grasping scores associated with any MA exposure and heavy exposure persisted to 3 years. There were no effects of MA exposure, including heavy exposure, on the Bayley Mental Development Index (MDI) or Psychomotor Development Index (PDI) at any or across age. Conclusions There were no differences in cognition as assessed by the BSID-II between the groups. There was a subtle MA exposure effect on fine motor performance at 1 year with the poorest performance observed in the most heavily exposed children. By 3 years, no differences in fine motor performance were observed. These findings suggest MA exposure has modest motor effects at 1 year that are mostly resolved by 3 years.</description><identifier>ISSN: 0892-0362</identifier><identifier>EISSN: 1872-9738</identifier><identifier>DOI: 10.1016/j.ntt.2010.10.004</identifier><identifier>PMID: 21256431</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Bayley ; Case-Control Studies ; Child Behavior - drug effects ; Child Behavior - psychology ; Child Development - drug effects ; Child, Preschool ; Cognition - drug effects ; Cross-Sectional Studies ; Emergency ; Female ; Humans ; Infant ; Infant Behavior - drug effects ; Infant Behavior - psychology ; Infant, Newborn ; Longitudinal Studies ; Male ; Medical Education ; Methamphetamine - toxicity ; Motor Activity - drug effects ; Neurodevelopment ; Peabody ; Pregnancy ; Prenatal exposure ; Prenatal Exposure Delayed Effects - chemically induced ; Prenatal Exposure Delayed Effects - physiopathology ; Prenatal Exposure Delayed Effects - psychology ; Social Class ; Surveys and Questionnaires</subject><ispartof>Neurotoxicology and teratology, 2011-01, Vol.33 (1), p.176-184</ispartof><rights>Elsevier Inc.</rights><rights>2010 Elsevier Inc.</rights><rights>Copyright © 2010 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c537t-465b7fcda58d614d30e4e16fdede944ec9b519140000f7f9535f63d661da0a9f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ntt.2010.10.004$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,778,782,883,3539,27911,27912,45982</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21256431$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Smith, Lynne M</creatorcontrib><creatorcontrib>LaGasse, Linda L</creatorcontrib><creatorcontrib>Derauf, Chris</creatorcontrib><creatorcontrib>Newman, Elana</creatorcontrib><creatorcontrib>Shah, Rizwan</creatorcontrib><creatorcontrib>Haning, William</creatorcontrib><creatorcontrib>Arria, Amelia</creatorcontrib><creatorcontrib>Huestis, Marilyn</creatorcontrib><creatorcontrib>Strauss, Arthur</creatorcontrib><creatorcontrib>Della Grotta, Sheri</creatorcontrib><creatorcontrib>Dansereau, Lynne M</creatorcontrib><creatorcontrib>Lin, Hai</creatorcontrib><creatorcontrib>Lester, Barry M</creatorcontrib><title>Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine</title><title>Neurotoxicology and teratology</title><addtitle>Neurotoxicol Teratol</addtitle><description>Abstract Background Methamphetamine (MA) use among pregnant women is an increasing problem in the United States. The impact of prenatal MA exposure on development in childhood is unknown. Objective To examine the effects of prenatal MA exposure on motor and cognitive development in children at 1, 2, and 3 years of age. Design/methods IDEAL enrolled 412 mother–infant pairs at four sites (Tulsa OK, Des Moines IA, Los Angeles CA, and Honolulu HI). MA subjects (n = 204) were identified by self report or GC/MS confirmation of amphetamine and metabolites in infant meconium. Comparison subjects (n = 208) were matched (race, birth weight, maternal education, and type of insurance), denied amphetamine use, and had a negative meconium screen. Both groups included prenatal alcohol, tobacco and marijuana use, but excluded use of opiates, lysergic acid diethylamide, phencyclidine or cocaine only. The Peabody Developmental Motor Scales (PDMS-2) were administered to the infants at the 1 and 3 year visits. This analysis includes a subsample (n = 350) of the IDEAL study with completed 1 and/or 3 year visits (n = 330 and 281, respectively). At each annual visit we also conducted the Bayley Scales of Infant Development (BSID-II) as a general evaluation of mental and motor development. The BSID-II analysis includes a subsample (n = 356) of the IDEAL study with completed 1, 2, and/or 3 year visits (n = 331, 288, and 278 respectively). GLM analysis conducted on the PDMS-2 and BSID-II examined the effects of MA exposure and heavy MA exposure (≥ 3 days of use/week), with and without covariates. Longitudinal analyses were used to examine the effects of MA exposure on changes in motor and cognitive performance over time. Results Heavy MA exposure was associated with significantly lower grasping scores than some and no use at 1 year (P = 0.018). In longitudinal analysis, lower grasping scores associated with any MA exposure and heavy exposure persisted to 3 years. There were no effects of MA exposure, including heavy exposure, on the Bayley Mental Development Index (MDI) or Psychomotor Development Index (PDI) at any or across age. Conclusions There were no differences in cognition as assessed by the BSID-II between the groups. There was a subtle MA exposure effect on fine motor performance at 1 year with the poorest performance observed in the most heavily exposed children. By 3 years, no differences in fine motor performance were observed. These findings suggest MA exposure has modest motor effects at 1 year that are mostly resolved by 3 years.</description><subject>Bayley</subject><subject>Case-Control Studies</subject><subject>Child Behavior - drug effects</subject><subject>Child Behavior - psychology</subject><subject>Child Development - drug effects</subject><subject>Child, Preschool</subject><subject>Cognition - drug effects</subject><subject>Cross-Sectional Studies</subject><subject>Emergency</subject><subject>Female</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant Behavior - drug effects</subject><subject>Infant Behavior - psychology</subject><subject>Infant, Newborn</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Medical Education</subject><subject>Methamphetamine - toxicity</subject><subject>Motor Activity - drug effects</subject><subject>Neurodevelopment</subject><subject>Peabody</subject><subject>Pregnancy</subject><subject>Prenatal exposure</subject><subject>Prenatal Exposure Delayed Effects - chemically induced</subject><subject>Prenatal Exposure Delayed Effects - physiopathology</subject><subject>Prenatal Exposure Delayed Effects - psychology</subject><subject>Social Class</subject><subject>Surveys and Questionnaires</subject><issn>0892-0362</issn><issn>1872-9738</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9Uk1v1DAUtBCILoUfwAX5ximLHTtOIqRKqOJLKuJQOFte-yXxktjBdlbdf1-nWyrKgdPTs2fm2TMPodeUbCmh4t1-61LaluSu3xLCn6ANbeqyaGvWPEUb0rRlQZgoz9CLGPeEkFpQ8hydlbSsBGd0g_pvPvmAlTNY-97ZZA-A_ZK0nyDiNAS_9MNaAfARVIjYd1j1gK3DerCjCeAw3Mw-gsHJ4zn3KqkRT5AGNc0DJDVZBy_Rs06NEV7d13P089PHH5dfiqvvn79efrgqdMXqVHBR7epOG1U1RlBuGAEOVHQGDLScg253FW0pz18hXd21Fas6wYwQ1Cii2o6do4uT7rzsJjAaXApqlHOwkwpH6ZWVj2-cHWTvD5IRxqqGZ4G39wLB_14gJjnZqGEclQO_RNkIwuqGC5GR9ITUwccYoHuYQolc85F7mfORaz7rUc4nc978_bwHxp9AMuD9CQDZpIOFIKO24DQYG0Anabz9r_zFP2w9Wme1Gn_BEeLeL8Fl9yWVsZREXq8Lsu4HzXbSRjTsFsvquKM</recordid><startdate>20110101</startdate><enddate>20110101</enddate><creator>Smith, Lynne M</creator><creator>LaGasse, Linda L</creator><creator>Derauf, Chris</creator><creator>Newman, Elana</creator><creator>Shah, Rizwan</creator><creator>Haning, William</creator><creator>Arria, Amelia</creator><creator>Huestis, Marilyn</creator><creator>Strauss, Arthur</creator><creator>Della Grotta, Sheri</creator><creator>Dansereau, Lynne M</creator><creator>Lin, Hai</creator><creator>Lester, Barry M</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>20110101</creationdate><title>Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine</title><author>Smith, Lynne M ; LaGasse, Linda L ; Derauf, Chris ; Newman, Elana ; Shah, Rizwan ; Haning, William ; Arria, Amelia ; Huestis, Marilyn ; Strauss, Arthur ; Della Grotta, Sheri ; Dansereau, Lynne M ; Lin, Hai ; Lester, Barry M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c537t-465b7fcda58d614d30e4e16fdede944ec9b519140000f7f9535f63d661da0a9f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Bayley</topic><topic>Case-Control Studies</topic><topic>Child Behavior - drug effects</topic><topic>Child Behavior - psychology</topic><topic>Child Development - drug effects</topic><topic>Child, Preschool</topic><topic>Cognition - drug effects</topic><topic>Cross-Sectional Studies</topic><topic>Emergency</topic><topic>Female</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant Behavior - drug effects</topic><topic>Infant Behavior - psychology</topic><topic>Infant, Newborn</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Medical Education</topic><topic>Methamphetamine - toxicity</topic><topic>Motor Activity - drug effects</topic><topic>Neurodevelopment</topic><topic>Peabody</topic><topic>Pregnancy</topic><topic>Prenatal exposure</topic><topic>Prenatal Exposure Delayed Effects - chemically induced</topic><topic>Prenatal Exposure Delayed Effects - physiopathology</topic><topic>Prenatal Exposure Delayed Effects - psychology</topic><topic>Social Class</topic><topic>Surveys and Questionnaires</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Smith, Lynne M</creatorcontrib><creatorcontrib>LaGasse, Linda L</creatorcontrib><creatorcontrib>Derauf, Chris</creatorcontrib><creatorcontrib>Newman, Elana</creatorcontrib><creatorcontrib>Shah, Rizwan</creatorcontrib><creatorcontrib>Haning, William</creatorcontrib><creatorcontrib>Arria, Amelia</creatorcontrib><creatorcontrib>Huestis, Marilyn</creatorcontrib><creatorcontrib>Strauss, Arthur</creatorcontrib><creatorcontrib>Della Grotta, Sheri</creatorcontrib><creatorcontrib>Dansereau, Lynne M</creatorcontrib><creatorcontrib>Lin, Hai</creatorcontrib><creatorcontrib>Lester, Barry M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neurotoxicology and teratology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Smith, Lynne M</au><au>LaGasse, Linda L</au><au>Derauf, Chris</au><au>Newman, Elana</au><au>Shah, Rizwan</au><au>Haning, William</au><au>Arria, Amelia</au><au>Huestis, Marilyn</au><au>Strauss, Arthur</au><au>Della Grotta, Sheri</au><au>Dansereau, Lynne M</au><au>Lin, Hai</au><au>Lester, Barry M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine</atitle><jtitle>Neurotoxicology and teratology</jtitle><addtitle>Neurotoxicol Teratol</addtitle><date>2011-01-01</date><risdate>2011</risdate><volume>33</volume><issue>1</issue><spage>176</spage><epage>184</epage><pages>176-184</pages><issn>0892-0362</issn><eissn>1872-9738</eissn><abstract>Abstract Background Methamphetamine (MA) use among pregnant women is an increasing problem in the United States. The impact of prenatal MA exposure on development in childhood is unknown. Objective To examine the effects of prenatal MA exposure on motor and cognitive development in children at 1, 2, and 3 years of age. Design/methods IDEAL enrolled 412 mother–infant pairs at four sites (Tulsa OK, Des Moines IA, Los Angeles CA, and Honolulu HI). MA subjects (n = 204) were identified by self report or GC/MS confirmation of amphetamine and metabolites in infant meconium. Comparison subjects (n = 208) were matched (race, birth weight, maternal education, and type of insurance), denied amphetamine use, and had a negative meconium screen. Both groups included prenatal alcohol, tobacco and marijuana use, but excluded use of opiates, lysergic acid diethylamide, phencyclidine or cocaine only. The Peabody Developmental Motor Scales (PDMS-2) were administered to the infants at the 1 and 3 year visits. This analysis includes a subsample (n = 350) of the IDEAL study with completed 1 and/or 3 year visits (n = 330 and 281, respectively). At each annual visit we also conducted the Bayley Scales of Infant Development (BSID-II) as a general evaluation of mental and motor development. The BSID-II analysis includes a subsample (n = 356) of the IDEAL study with completed 1, 2, and/or 3 year visits (n = 331, 288, and 278 respectively). GLM analysis conducted on the PDMS-2 and BSID-II examined the effects of MA exposure and heavy MA exposure (≥ 3 days of use/week), with and without covariates. Longitudinal analyses were used to examine the effects of MA exposure on changes in motor and cognitive performance over time. Results Heavy MA exposure was associated with significantly lower grasping scores than some and no use at 1 year (P = 0.018). In longitudinal analysis, lower grasping scores associated with any MA exposure and heavy exposure persisted to 3 years. There were no effects of MA exposure, including heavy exposure, on the Bayley Mental Development Index (MDI) or Psychomotor Development Index (PDI) at any or across age. Conclusions There were no differences in cognition as assessed by the BSID-II between the groups. There was a subtle MA exposure effect on fine motor performance at 1 year with the poorest performance observed in the most heavily exposed children. By 3 years, no differences in fine motor performance were observed. These findings suggest MA exposure has modest motor effects at 1 year that are mostly resolved by 3 years.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>21256431</pmid><doi>10.1016/j.ntt.2010.10.004</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0892-0362
ispartof Neurotoxicology and teratology, 2011-01, Vol.33 (1), p.176-184
issn 0892-0362
1872-9738
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3033584
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Bayley
Case-Control Studies
Child Behavior - drug effects
Child Behavior - psychology
Child Development - drug effects
Child, Preschool
Cognition - drug effects
Cross-Sectional Studies
Emergency
Female
Humans
Infant
Infant Behavior - drug effects
Infant Behavior - psychology
Infant, Newborn
Longitudinal Studies
Male
Medical Education
Methamphetamine - toxicity
Motor Activity - drug effects
Neurodevelopment
Peabody
Pregnancy
Prenatal exposure
Prenatal Exposure Delayed Effects - chemically induced
Prenatal Exposure Delayed Effects - physiopathology
Prenatal Exposure Delayed Effects - psychology
Social Class
Surveys and Questionnaires
title Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T13%3A54%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Motor%20and%20cognitive%20outcomes%20through%20three%20years%20of%20age%20in%20children%20exposed%20to%20prenatal%20methamphetamine&rft.jtitle=Neurotoxicology%20and%20teratology&rft.au=Smith,%20Lynne%20M&rft.date=2011-01-01&rft.volume=33&rft.issue=1&rft.spage=176&rft.epage=184&rft.pages=176-184&rft.issn=0892-0362&rft.eissn=1872-9738&rft_id=info:doi/10.1016/j.ntt.2010.10.004&rft_dat=%3Cproquest_pubme%3E860378466%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=860378466&rft_id=info:pmid/21256431&rft_els_id=1_s2_0_S0892036210001868&rfr_iscdi=true